doc. MUDr. Igor Kiss, Ph.D., MBA
Department head, Comprehensive Cancer Care Department
Total number of publications: 245
2020
-
Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 Patients
CANCER MANAGEMENT AND RESEARCH, year: 2020, volume: 12, edition: 2020, DOI
-
Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice
Targeted Oncology, year: 2020, volume: 15, edition: 2, DOI
-
Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy
CANCER GENOMICS & PROTEOMICS, year: 2020, volume: 17, edition: 3, DOI
2019
-
Časný kolorektální karcinom (klinická stádia I. a II.) – diagnostika a léčba
Year: 2019
-
Diagnosis and treatment of early colorectal cancer (stages I and II): a trustworthy clinical practice guideline
Year: 2019, type: Conference abstract
-
MicroRNA Biogenesis Pathway Genes Are Deregulated in Colorectal Cancer
International Journal of Molecular Sciences, year: 2019, volume: 20, edition: 18, DOI
-
Podání vysokodávkovaného metotrexátu na standardním oddělení - zkušenosti pracoviště s náročnou léčbou.
Klinická onkologie, year: 2019
-
Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis
CANCER MANAGEMENT AND RESEARCH, year: 2019, volume: 11, edition: 2019, DOI
-
Type II hypersensitivity reactions after oxaliplatin rechallenge can be life threatening.
International Immunopharmacology, year: 2019, volume: 74:105728, DOI
-
Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national database
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, year: 2019, volume: 37, edition: 4, DOI